INDUSTRY SYMPOSIUM 7
13:15 - 15:15 G104-105
Optimal Therapy of SHPT: Is it Possible?
Chairs: Marc Vervloet, Amsterdam, The Netherlands
Armando L. Negri, Buenos Aires, Argentina
Lessons learned from VITAL, IMPACT and PRIMO
Daniel Coyne, St. Louis, USA
Measuring PTH: How SHPT treatment is affected by the assay used and type of PTH measured
Berthold Hocher, Potsdam, Germany
When VitD treatment fails; what is next?
Mario Cozzolino, Milan, Italy
Question and answer
Organised by ABBVIE